HTRS/Novo Nordisk Inc. Clinical Scholar Award (CSA)

The HTRS/Novo Nordisk Clinical Scholar Award in Hemophilia and Rare Bleeding Disorders is one academic year, supported by an educational grant to HTRS from Novo. During the clinical scholar year, the 2025 CSA recipient is mentored by an experienced MD, MD/PhD, or DO working in hemophilia and rare bleeding disorders at an established U.S.-based hemostasis treatment center (HTC), hospital, or university. Applicants must present an education plan for the CSA year to obtain expertise in the clinical care of patients with hemophilia and rare bleeding disorders. The maximum grant is $119,600 USD, including an $80,000 stipend for the award recipient and a $39,600 honorarium for the primary mentor at the U.S.-based HTC, hospital or university identified in the applicant’s proposal.

Learn More & Apply

Total Award

Funding for a one-year clinical or translational research project

Requirements

Applicants must be committed to academic research careers in hemostasis and thrombosis at North American medical institutions.

Status & Deadlines

Applications for the 2024 cycle are closed.

Not a Member?

Visit the HTRS Membership Page to join.

2025 HTRS/Novo Nordisk Inc. Clinical Scholar Award Recipient

JESSICA GARCIA, MD

Assistant Professor of Pediatrics | University of Texas Southwestern Medical Center
HTRS/Novo Nordisk Clinical Scholar Award for Hemophilia A and Rare Bleeding Disorders
Mentor: Ayesha Zia, MD, MSCS, University of Texas Southwestern

Jessica Garcia, MD is an Assistant Professor of Pediatrics in the Division of Pediatric Hematology/Oncology at the University of Texas Southwestern Medical Center/Children’s Health. Her clinical focus is on hemostasis, and she currently leads the care of persons with hemophilia. Her overarching career goal is to conduct research that informs and improves clinical care in hemophilia.

During her Clinical Scholar Award period, Dr. Garcia will be working under the guidance of her primary mentor, Ayesha Zia, MD, MSCS. Dr. Garcia aims to enhance her expertise in the management of patients with hemophilia who are at risk for or have established joint disease by continuing to hone her expertise in global and special coagulation assays, gain proficiency in joint health evaluation through point of care ultrasound and develop and implement a joint clinic for persons with hemophilia and other bleeding disorders.

Previous Recipients

Questions? Email Jennifer Ziegler, Director, Award Programs and Career Development, at [email protected].